常见的皮肤相关的过敏性疾病包括荨麻疹、湿疹、特应性皮炎等。李珺莹介绍，荨麻疹是临床中较 为常见的一种变态反应性皮肤疾病，主要临床特点为边缘清楚，大小不一的瘙痒性风团。大部分皮疹， 多则一天左右，少则几分钟或几小时，便可自行消退，消退后不留任何痕迹，但病情严重者会出现喉头 水肿，甚至窒息。 专家介绍，湿疹是由多种内外因素引起的瘙痒剧烈的一种皮肤炎症反应，属于一种过敏刺激因素引 发的疾病。患者的过敏体质是本病的重要因素，与遗传有关，可随年龄的增长、环境改变而改变，过度 忧虑、紧张、情绪激动、失眠、劳累等都可能诱发或加重病情。 特应性皮炎是一种与遗传过敏体质有关的慢性、复发性、炎症性皮肤病，患者常伴有过敏性鼻炎、 哮喘、过敏性结膜炎或食物过敏等其他过敏性疾病。 新华社天津7月8日电（记者张建新、栗雅婷）今年7月8日是第21个"世界过敏性疾病日"。夏日炎 炎，高温高湿的天气为过敏性疾病发作"推波助澜"，尤其是过敏性皮肤病患者往往更易"中招"。专家提 醒，患者应明确并远离过敏原，清淡饮食、规律作息，调节自身免疫力。 过敏，即变态反应、超敏反应，指异常的、过高的免疫应答。天津市中医药研究院附属医院皮肤科 主任医师李珺莹表 ...

Core Insights - Zhejiang Iwu Biological Technology Co., Ltd. has made significant progress in the field of allergic disease diagnostics with the approval of its "Dermatitis Diagnostic Patch 02" for clinical trials by the National Medical Products Administration [1][5] Group 1: Product Development - The "Dermatitis Diagnostic Patch 02" focuses on diagnosing three common allergens: Kathon, p-phenylenediamine, and formaldehyde, which are frequently encountered in daily life and are known to cause allergic contact dermatitis [4][6] - The clinical trial process will follow a rigorous drug development protocol, including Phase I, II, and III trials to assess safety, efficacy, and dosage [5][6] Group 2: Market Position and Impact - Iwu Biological is a leading domestic pharmaceutical company specializing in the research and innovation of allergic disease diagnostics and treatments, with a strong R&D team and a history of successful product launches [6][7] - The approval of the "Dermatitis Diagnostic Patch 02" is expected to enhance the company's competitiveness in the diagnostic market and contribute to the development of the allergic disease diagnostics sector in China [6][7]